Logo image of URGN

UROGEN PHARMA LTD (URGN) Stock News

NASDAQ:URGN - Nasdaq - IL0011407140 - Common Stock - Currency: USD

9.955  +0.27 (+2.73%)

URGN Latest News, Press Relases and Analysis

News Image
9 days ago - Benzinga

UroGen Pharma Touts Four-Year Response With Urothelial Cancer Drug Study, Highlights Potential For Bladder Cancer Candidates

UroGen Pharma reports strong long-term data for Jelmyto and UGN-102 in cancer studies and shares promising early results for UGN-301 in bladder cancer.